Q1 Report, 2003

Interim Report 1, January - March 2003 24 April 2003 Nobel Biocare Holding AG Group * Net profit increased by 38.7% to EUR 14.7 million in the first quarter confirming that further profitability improvements were achieved in the production related processes and that operating expenses were kept under control. * Revenue increased by 11.8% (currency-adjusted) to EUR 79.8 million in the first quarter. After a soft January, with major activities focused on internal sales training, revenue growth has improved from February onwards. Revenue trends are especially strong in North America and Asia Pacific while Europe shows good trends on all markets except for the German speaking countries and Italy. * The high market activity level under the Crown & Bridge & Implant strategy, positive uptake of the new product offer confirmed by high sales volume of starter kits, improving sales growth trends from February, extensive training & education activities for both present and potential customers and a strong launch program for the remainder of the year make us confident to reach all the targets for 2003. * The Nobel Biocare World Congress was held in Las Vegas 2-5 April. The 2 300 participants had the possibility to see a sophisticated scientific program, including two live surgeries with the Teeth-in-an-Hour concept as well as the latest developments in science and products. The feedback from the attendees was very positive. 24 April 2003 NOBEL BIOCARE HOLDING AG Heliane Canepa President & CEO Further information is available (after AGM and Tel conference) from: Harrieth Sundaeus, Chief Financial Officer, tel. +46 31 81 88 48, +46 708 81 88 48 Gunilla Ekholtz, Investor Relations Officer, tel. +46 31 81 88 36, +46 708 81 88 36 ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2003/04/24/20030424BIT00030/wkr0001.doc The full report http://www.waymaker.net/bitonline/2003/04/24/20030424BIT00030/wkr0002.pdf The full report

About Us

Nobel Biocare is the world leader in innovative esthetic dental solutions with the brands Brånemark System® ,Replace® Select and Procera®.Nobel Biocare has around 1,300 employees and, in 2001 net sales totaled SEK 2 663 million. The company's headquarters are located in Gothenburg, Sweden. Nobel Biocare has its own sales organizations in 27 countries. The shares of the parent company Nobel Biocare Holding AG are listed on both the SWX Swiss Exchange and the Stockholm Stock Exchange.